Contact
Allon Home Page
  ProfileLeadershipIn the News TechnologyMarketIndicationsPublications Development StatusAL-108AL208Pre-clinicalPartnering News ReleasesInformation RequestShareholder ReportsConference/WebStock QuoteAnalyst RequestInformation Request
 

May 1, 2008
Allon data demonstrate potential of AL-309 as a new neuropathy treatment

February 20, 2008
Allon to study AL-108 drug distribution in Alzheimer's patients

February 12, 2008
Allon’s CEO presenting at BIO CEO conference in NYC,
Allon’s founder honoured for neuroscience research

 arrow

Interview
Gordon McCauley
CEO

 

Copyright 2005 Allon Therapeutics Inc.  See legal terms for use of this site.